SCHEMBL31513029

SCHEMBL31513029

Fc1c(Br)ccc2c(I)n[nH]c12

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GPR17 Q13304 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22531920 1.00 GPR17 (0.33) GPR17
SCHEMBL31358052 0.81 AR (0.33) —
SCHEMBL22532396 0.79 PDPK1 (0.43) GPR17
SCHEMBL31539831 0.78 GPR17 (0.33) GPR17
SCHEMBL34465256 0.78 CHEK1 (0.38) GPR17
SCHEMBL31331228 0.78 — —
SCHEMBL31574996 0.74 ALOX5AP (0.36) —
SCHEMBL31539852 0.74 MAPK1 (0.37) GPR17
SCHEMBL16724769 0.73 NOS1 (0.41) —
SCHEMBL31127684 0.73 NOS1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025052129-A1 PYRIDINE DERIVATIVES WHICH ACT AS INHIBITORS OF MPTP. NRG THERAPEUTICS LTD (GB) 2025-03-13 — — WO disclosed
WO-2025049964-A1 BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. (US) 2025-03-06 — — WO disclosed
Send feedback